SCHEMBL25797969

SCHEMBL25797969

Cc1cc(N[C@@H]2CCCN(C)C2)nnc1-c1ccc(F)c(Cl)c1

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IL1B P01584 14/20 0.64
NLRP3 Q96P20 9/20 0.63
AXL P30530 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25798593 0.92 NLRP3 (0.63) IL1BNLRP3
SCHEMBL25798128 0.91 NLRP3 (0.66) IL1BNLRP3
SCHEMBL25798116 0.91 NLRP3 (0.66) IL1BNLRP3
SCHEMBL25798667 0.89 IL1B (0.65) IL1BNLRP3
SCHEMBL25798457 0.88 IL1B (0.74) IL1BNLRP3
SCHEMBL25797972 0.87 IL1B (0.61) IL1BNLRP3
SCHEMBL25797812 0.86 NLRP3 (0.78) IL1BNLRP3
SCHEMBL25797982 0.85 IL1B (0.70) IL1BNLRP3
SCHEMBL25798376 0.85 NLRP3 (0.60) IL1BNLRP3
SCHEMBL25797819 0.84 NLRP3 (0.65) IL1BNLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023129987-A1 PYRIDAZINE DERIVATIVES AS MODULATORS OF NLRP3 INFLAMMASOME AND RELATED METHODS Neumora Therapeutics, Inc. (US) 2023-07-06 WO disclosed